Literature DB >> 10914041

Transient transfection assay of cell death genes.

M Miura1, J Yuan.   

Abstract

In conclusion, transient transfection is an efficient and powerful method to determine quickly whether a gene has a detrimental effect on cell survival. We have described a variety of assay systems from which to choose. Each system has its own advantages and disadvantages. It is important to back up any experimental conclusion with more than one type of assay if possible. In addition, one must consider the fact that transient transfection can often achieve artificially high levels of a protein product that may be unrealistic in vivo. High levels of certain proteins may have an adverse effect on cell survival even when they have nothing to do with apoptosis in vivo. Thus, we must emphasize here that a transient transfection assay is just the first test to determine the function of a gene.

Mesh:

Substances:

Year:  2000        PMID: 10914041     DOI: 10.1016/s0076-6879(00)22044-2

Source DB:  PubMed          Journal:  Methods Enzymol        ISSN: 0076-6879            Impact factor:   1.600


  3 in total

1.  Apoptotic regulation by the Crk adapter protein mediated by interactions with Wee1 and Crm1/exportin.

Authors:  Jesse J Smith; D Ashley Richardson; Jan Kopf; Minoru Yoshida; Robert E Hollingsworth; Sally Kornbluth
Journal:  Mol Cell Biol       Date:  2002-03       Impact factor: 4.272

2.  HSP72 protects cells from ER stress-induced apoptosis via enhancement of IRE1alpha-XBP1 signaling through a physical interaction.

Authors:  Sanjeev Gupta; Ayswaria Deepti; Shane Deegan; Fernanda Lisbona; Claudio Hetz; Afshin Samali
Journal:  PLoS Biol       Date:  2010-07-06       Impact factor: 8.029

3.  Expression and function of the human androgen-responsive gene ADI1 in prostate cancer.

Authors:  Shane W Oram; Junkui Ai; Gina M Pagani; Moira R Hitchens; Jeffrey A Stern; Scott Eggener; Michael Pins; Wuhan Xiao; Xiaoyan Cai; Riffat Haleem; Feng Jiang; Thomas C Pochapsky; Lizbeth Hedstrom; Zhou Wang
Journal:  Neoplasia       Date:  2007-08       Impact factor: 5.715

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.